Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6073-6082
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6073
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6073
Table 1 Description of the patients included in the two groups, n (%)
| oXiris® group (n = 26) | CRRT group (n = 19) | χ2 | P value | |
| Management before | 0.309f | 1 | ||
| HSCT | 69.23 (18) | 68.42 (13) | ||
| Chemotherapy | 23.08 (6) | 19.23 (5) | ||
| CAR-T | 7.69 (2) | 5.26 (1) | ||
| Source of infection | 4.218f | 0.592 | ||
| Positive blood culture | 50 (13) | 63.15 (12) | ||
| Severe pneumonia | 30.77 (8) | 26.32 (5) | ||
| Liver abscess | 7.69 (2) | |||
| Severe acute pancreatitis | 7.69 (2) | |||
| Splenic abscess | 3.85 (1) | 5.26 (1) | ||
| Skin soft tissue infection | 5.26 (1) | |||
| Respiratory support | 0.002 | 0.964 | ||
| Invasive ventilation | 73.08 (19) | 73.6 (14) | ||
| HFNC or face mask | 26.92 (7) | 26.4 (5) | ||
| APACHE II | 26.5 (20.75, 32.25) | 29.5 (22.0, 31.25) | -0.431z | 0.667 |
| Outcome | ||||
| ICU stay (d) | 9.5 (5.75, 22.5) | 10.5 (6.5, 24.0) | 0z | 1 |
| Mortality (%) | 34.60 | 57.80 | 2.409 | 0.121 |
- Citation: Wang J, Wei SR, Ding T, Zhang LP, Weng ZH, Cheng M, Zhou Y, Zhang M, Liu FJ, Yan BB, Wang DF, Sun MW, Cheng WX. Continuous renal replacement therapy with oXiris® in patients with hematologically malignant septic shock: A retrospective study. World J Clin Cases 2023; 11(26): 6073-6082
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6073.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6073